The landscape of diabetes care is evolving with the introduction of GLP-1 patches . These convenient delivery systems offer a possibly more comfortable alternative to injections for individuals dealing with diabetes mellitus type 2 . They deliver a GLP-1 agonist directly through the dermis , circ